Effects of using a different kind of smokeless tobacco on cardiac parameters: "Maraş powder"

AKSU, EKREM; Sökmen, Gülizar; BÜYÜKBEŞE, M. Akif; GÜVEN, Aytekin; KÖKSAL, NURHAN; cetinkaya, Ali; ÇAĞLAYAN, Ç. Emre

Effects of using a different kind of smokeless tobacco on cardiac parameters: "Maraş powder"

Aytekin GÜVEN, (Sütçü İmam Üniversitesi, Tıp Fakültesi, Kardiyoloji Anabilim Dalı, Kahramanmaraş, Türkiye)

Nurhan KÖKSAL, (Kahramanmaraş Sütçü İmam Üniversitesi, Tıp Fakültesi, Göğüs Hastalıkları Anabilim Dalı, Kahramanmaraş, Türkiye)

M. Akif BÜYÜKBEŞE, (Kahramanmaraş Sütçü İmam Üniversitesi, Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Kahramanmaraş, Türkiye)

Ali ÇETİNKAYA, (Kahramanmaraş Sütçü İmam Üniversitesi, Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Kahramanmaraş, Türkiye)

Gülizar SÖKMEN, (Sütçü İmam Üniversitesi, Tıp Fakültesi, Kardiyoloji Anabilim Dalı, Kahramanmaraş, Türkiye)

Ekrem AKSU, (Sütçü İmam Üniversitesi, Tıp Fakültesi, Kardiyoloji Anabilim Dalı, Kahramanmaraş, Türkiye)

Ç. Emre ÇAĞLAYAN (Sütçü İmam Üniversitesi, Tıp Fakültesi, Kardiyoloji Anabilim Dalı, Kahramanmaraş, Türkiye)

Anadolu Kardiyoloji Dergisi

2 2

Yıl: 2003 Cilt: 3 Sayı: 3 Sayfa Aralığı: 230 - 235 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Effects of using a different kind of smokeless tobacco on cardiac parameters: "Maraş powder"

Öz:

Amaç: Yurdumuzun Güneydoğu Anadolu bölgesinde "Maraş Otu" adı verilen bitkisel bir toz, sigara yerine yaygın olarak kullanılmaktadır. Bu tozun N. rustica L. tütününden yapıldığı tespit edilmiştir. Çalışmamız, Maraş Otu kullanımının sigara kadar zararlı olup olmadığını değerlendirmek amacı ile yapıldı. Yöntem: Çalışmaya, 45 Maraş Otu kullanıcısı (Grup I) ve sigara içen 32 kişi (Grup II), kontrol grubu olarak sigara veya Maraş Otu kullanmayan 30 sağlıklı olgu (Grup III) dahil edildi. Ventriküler repolarizasyon parametrelerini değerlendirmek için tüm olguların 50 mm/sn hızında elektrokardiyografileri çekildi. Ayrıca sistolik ve diyastolik fonksiyon parametreleri değerlendirmek için ekokardiyografik ölçümleri yapıldı. Bulgular: Her üç grupta da ventriküler repolarizasyon parametreleri arasında fark yoktu (p>0.05). Ekokardiyografik değerlendirmede üç grupta da sistolik fonksiyon parametreleri benzer bulundu. Grup I ve grup II'de sol ventrikül erken doluş zamanı kontrol grubuna göre daha düşüktü (p=0.03, p=0.02). Bu gruplarda, atriyal doluş zamanı (p=0.02, p=0.02) ve deselerasyon zamanı ise (p<0.01, p<0.01) kontrol grubuna göre daha yüksek bulundu. İzovolümetrik relaksasyon zamanı grup I ve grup II'de kontrol grubuna göre artmış bulundu (p=0.02, p=0.03). Grup I ve grup II'de total kolesterol (p=0.03, p=0.02), LDL kolesterol (p<0.01, p<0.01) ve trigliserid (p<0.01, p<0.01) düzeyleri grup III'den yüksek bulunurken HDL düzeyleri düşük bulundu (p=0.02, p<0.01). Sonuç: Maraş Otunun en az sigara kadar zararlı olduğu ve kardiyovasküler sistem üzerine olumsuz etkileri bulunduğu kanısına vardık. Bize göre "Maraş Otu" dumansız bir tütün kullanımıdır.

Anahtar Kelime: Kan akım hızı Kalp damar fizyolojisi Risk faktörleri Maraş otu Ekokardiyografi Elektrokardiyografi Olgu kontrol çalışmaları Sigara içme Ventriküler fonksiyon, sol Tütün

Konular: Kalp ve Kalp Damar Sistemi

Farklı bir tip dumansız tütün kullanımının kardiyak parametreler üzerine etkisi: "Maraş otu"

Öz:

Objective: A plant powder called "Maraş Powder" has been used widely instead of cigarette in the South-Eastern region of Turkey. It was confirmed that this powder has been made of tobacco N. rustica L. Our aim was to investigate whether the use of Maraş Powder is as harmful as cigarette smoking or not. Methods: Forty-five Maraş Powder users (Group I), 32 persons who smoked cigarette (control-Group II) and 30 healthy persons neither smoking nor using Maraş Powder (Group III) were included into the study. Laboratory investigations, electrocardiography and echocardiography were performed in all participants of the study. For evaluation of the ventricular repolarization parameters, 50 mm/sec ECG recordings were used. Echocardiographic investigation was performed for assessment systolic and diastolic function. Results: No differences were found by means of ventricular repolarization parameters among the three groups (p>0.05). Echocardiographic investigation revealed similar systolic function results in all of the three groups. There was reduced early filling velocity of the left ventricle (p=0.03, p=0.02) and increased filling velocity of the atrial component (p=0.02, p=0.02) in group I and group II. When they were compared to group III, deceleration time was also increased (p<0.01, p<0.01). Isovolumetric relaxation time was higher in group I and group II than that of group III (p=0.02, p=0.03). In group I and group II, total cholesterol (p=0.03, p=0.02), LDL-cholesterol (p<0.01, p<0.01) and triglyceride levels (p<0.01, p<0.01) were found to be higher than those of group III, whereas HDL levels were lower (p=0.02, p<0.01). Conclusion: As a result, we thought that Maraş Powder is as harmful as cigarette smoking and it has similar negative effects on cardiovascular system. In our opinion, "Maraş Powder" is a smokeless tobacco use.

Anahtar Kelime: Maras powder Echocardiography Electrocardiography Case Control Studies Smoking Ventricular Function, Left Tobacco Blood Flow Velocity Cardiovascular Physiology Risk Factors

Konular: Kalp ve Kalp Damar Sistemi

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. McBride PE. The health consequences of smoking. Cardiovascular diseases. Med Clin North Am 1992; 76: 333-8.
2. Qiao Q, Tervahauta M, Nissinen A, Tuomilehto J. Mortality from all cause and from coronary heart disease related to smoking and changes in smoking during a 35-year follow-up of middle-aged Finnish men. Eur Heart J 2000; 21: 1570-1.
3. Bartecchi CE, Mackenzie TD, Schrier RW. The human cost of tobacco use. N Engl J Med 1994;330:907-12.
4. Vlicatstra RE, Kronmal RA, Oberman A, Frye RL, Killip I. Effect of cigarette smoking on survival of patients with angiographically documented coronary artery disease. JAMA 1986;255:1023-7.
5. Hallstrom AP, Cobb LA, Ray R. Smoking is a risk factor for recurrence of sudden cardiac arrest. N Engl J Med 1986;314:271-5.
6. Barry J, Mead K, Nabel EG, et al. Effect of smoking on the activity of ischemic heart disease. JAMA 1989;261:398-402.
7. Cavender JB, Rogers WJ, Fisher LD, Gersh BJ, Coggin CJ, Myers WO. Effects of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the Coronary Artery Surgery Study (CASS): 10-year follow-up. CASS Investigators. J Am Coll Cardiol 1992;2:287-94.
8. Ozkul Y, Donmez H, Erenmemisoglu A, Demirtas H, Imamoglu N. Induction of micronuclei by smokeless tobacco on buccal mucosa cells of habitual users. Mutagenesis 1997;12:285-7.
9. Yamamoto K, Masuyama T, Tanouchi J,et al. Peak early diastolic filling velocity may decrease with preload augmentation: effect of concomitant increase in a rate of left atrial pressure drop in early diastole. J Am Soc Echocardiogr 1993;6:245-50.
10. Terry ML, Berkowitz HD, Kerstein MD. Tobacco. Its impact on vascular disease. Surg Clin North Am 1998;78:409-29.
11. Felding JE. Smoking: Health effects and control. N Engl J Med 1985;313:491-8.
12. Traber MG, Van der Vliet A, Reznick AZ, Cros CE. Smoking and pulmonary and cardiovascular diseases. Clin Chest Med 2000;2:173-87.
13. Farmer JA, Gotto AM. Dyslipidemia and other risk factors for coronary artery disease. In: Braunwald E. Editor. Heart Disease. A textbook of cardiovascular medicine. Philadelphia: WB Saunders Co; 1997. p.1126-61.
14. Rigotti NA, Pasternak RC. Cigarette smoking and coronary heart disease: risk and management. Cardiol Clin 1996;14:51-68.
15. Robertson D, Tseng JC, Appolsamy M. Smoking and mechanisms of cardiovascular control. Am Heart J 1988;115:258-66.
16. Benowitz N. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med 1988; 319:1318-28.
17. Christen AG. The impact of tobacco use and cessation on oral and dental disease and condition. Am J Med 1993;1:23-31.
18. Willett WC, Green A, Stampfer MJ, et al. Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med 1987;317:1303-8.
19. Chalon SVH, Moreno H JR, Benowitz NL, Hoffman BB, Blaschke TF. Nicotine impairs endothelium-dependent dilatation in human veins in vivo. Clin Pharmacol Ther 2000;67:391-7.
20. Miller VM, Lewis DA, Rud KS, Offord KP, Croghan IT, Hurt RD. Plasma nitric oxide before and after smoking cessation with nicotine nasal spray. J Clin Pharmacol 1998;38:22-7.
21. Saitoh F, Noma M, Kawashima N. The alkaloid contents of sixty nicotine species. Phytochemistry 1985;24:477-80.
22. Erenmemisoglu A, Tekol Y, Kartal M, Kurucu S. The use of a smokeless tobacco in our country “Maraş Powder”. Turk J Med Sci 1992;16:567-76.
23. Russell MA, Jarvis M, Iyer R, et al. Relation of nicotine yield of cigarettes to blood nicotine concentrations in smokers. BMJ 1980;280:972-6.
24. Tang G, Hanna TS, Wang R. Effects of nicotine on K+ channel currents in vascular smooth muscle cells from rat tail arteries. Eur J Pharmacol 1999;364:247-54.
25. Westman EC. Does smokeless tobacco cause hypertension? South Med J 1995;88:716-20.
26. Varanda WA, Aracava Y, Sherby SM, VanMeter WG, Eldefrawi ME, Albuquerque EX. The acetylcholine receptor of the neuromuscular junction recognizes mecamylamine as a noncompetitive antagonist. Mol Pharmacol 1985;28:128-37.
27. Davis JW, Shelton L, Eingenberg DA, Hignite CE, Watanbe IS. Effects of tobacco and non-tobacco cigarette smoking on endothelium and platelets. Clin Pharmacol Ther 1985;37:529-33.
28. Davis JW, Shelton L, Watanabe IS, Arnold J. Passive smoking effects endothelium and platelets. Arch Intern Med 1989;149:386-9.
29. Belch JJ, McArdle BM, Burns P, Lowe GD, Forbes CD. The effects of acute smoking on platelet behavior, fibrinolysis and hemorheology in habitual smokers. Thromb Heamost 1984;51:6-8.
30. Muscat E, Harris RE, Haley N, Wyn der EL. Cigarette smoking and plasma cholesterol. Am Heart J 1991;121:141-7.
31. Steiner G, Schwartz L, Shumok S, Poapst M. The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease. Circulation 1987;75:124-30.
32. Tall AR. An overview of reverse cholesterol transport. Eur Heart J 1998;19 Suppl A:A31-5.
33. Kjiterovich PO Jr. The antiatherogenic role of high-density lipoprotein cholesterol. Am J Cardiol 1998;82:13-21.
34. Escobedo LG, Zack MM. Comparison of sudden and non sudden coronary deaths in the United States. Circulation 1996;93:2033-6.
35. Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death: epidemiology, transient risk, and intervention assessment. Ann Intern Med 1993;119:1187-97.
36. Algra A, Tijesen JGP, Roelandt RTC, Pool J, Lubsen J. OTc prolongation measured by standard 12 lead electrocardiograph is an independent risk factor for sudden death due to cardiac arrest. Circulation 1991;83:1888-92.
37. Dilaveris P, Pantazis A, Gialafos E, Triposkiadis F, Gialafos J. The effects of cigarette smoking on the heterogeneity of ventricular repolarization. Am Heart J 2001;142:833-7.
38. Higman DJ, Strachan AM, Buttery L, et al. Smoking impairs the activity of endothelial nitric oxide syntheses in saphenous vein. Arteriosclerosis Thrombosis and Vascular Biology 1996;16:546-52.
39. Kiowski W, Linder L, Stoschitzky K, et al. Diminished vascular response to inhibition of endothelium derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers. Circulation 1994;90:27-34.
40. Wang H, Shi H, Zhang L, et al. Nicotine is a potent blocker of the cardiac A-Type K+ channels. Effects on cloned Kv4.3 channels and native transient outward current. Circulation 2000;102:1165-71.

APA	GÜVEN A, KÖKSAL N, BÜYÜKBEŞE M, cetinkaya A, Sökmen G, AKSU E, ÇAĞLAYAN Ç (2003). Effects of using a different kind of smokeless tobacco on cardiac parameters: "Maraş powder". , 230 - 235.
Chicago	GÜVEN Aytekin,KÖKSAL NURHAN,BÜYÜKBEŞE M. Akif,cetinkaya Ali,Sökmen Gülizar,AKSU EKREM,ÇAĞLAYAN Ç. Emre Effects of using a different kind of smokeless tobacco on cardiac parameters: "Maraş powder". (2003): 230 - 235.
MLA	GÜVEN Aytekin,KÖKSAL NURHAN,BÜYÜKBEŞE M. Akif,cetinkaya Ali,Sökmen Gülizar,AKSU EKREM,ÇAĞLAYAN Ç. Emre Effects of using a different kind of smokeless tobacco on cardiac parameters: "Maraş powder". , 2003, ss.230 - 235.
AMA	GÜVEN A,KÖKSAL N,BÜYÜKBEŞE M,cetinkaya A,Sökmen G,AKSU E,ÇAĞLAYAN Ç Effects of using a different kind of smokeless tobacco on cardiac parameters: "Maraş powder". . 2003; 230 - 235.
Vancouver	GÜVEN A,KÖKSAL N,BÜYÜKBEŞE M,cetinkaya A,Sökmen G,AKSU E,ÇAĞLAYAN Ç Effects of using a different kind of smokeless tobacco on cardiac parameters: "Maraş powder". . 2003; 230 - 235.
IEEE	GÜVEN A,KÖKSAL N,BÜYÜKBEŞE M,cetinkaya A,Sökmen G,AKSU E,ÇAĞLAYAN Ç "Effects of using a different kind of smokeless tobacco on cardiac parameters: "Maraş powder"." , ss.230 - 235, 2003.
ISNAD	GÜVEN, Aytekin vd. "Effects of using a different kind of smokeless tobacco on cardiac parameters: "Maraş powder"". (2003), 230-235.

APA	GÜVEN A, KÖKSAL N, BÜYÜKBEŞE M, cetinkaya A, Sökmen G, AKSU E, ÇAĞLAYAN Ç (2003). Effects of using a different kind of smokeless tobacco on cardiac parameters: "Maraş powder". Anadolu Kardiyoloji Dergisi, 3(3), 230 - 235.
Chicago	GÜVEN Aytekin,KÖKSAL NURHAN,BÜYÜKBEŞE M. Akif,cetinkaya Ali,Sökmen Gülizar,AKSU EKREM,ÇAĞLAYAN Ç. Emre Effects of using a different kind of smokeless tobacco on cardiac parameters: "Maraş powder". Anadolu Kardiyoloji Dergisi 3, no.3 (2003): 230 - 235.
MLA	GÜVEN Aytekin,KÖKSAL NURHAN,BÜYÜKBEŞE M. Akif,cetinkaya Ali,Sökmen Gülizar,AKSU EKREM,ÇAĞLAYAN Ç. Emre Effects of using a different kind of smokeless tobacco on cardiac parameters: "Maraş powder". Anadolu Kardiyoloji Dergisi, vol.3, no.3, 2003, ss.230 - 235.
AMA	GÜVEN A,KÖKSAL N,BÜYÜKBEŞE M,cetinkaya A,Sökmen G,AKSU E,ÇAĞLAYAN Ç Effects of using a different kind of smokeless tobacco on cardiac parameters: "Maraş powder". Anadolu Kardiyoloji Dergisi. 2003; 3(3): 230 - 235.
Vancouver	GÜVEN A,KÖKSAL N,BÜYÜKBEŞE M,cetinkaya A,Sökmen G,AKSU E,ÇAĞLAYAN Ç Effects of using a different kind of smokeless tobacco on cardiac parameters: "Maraş powder". Anadolu Kardiyoloji Dergisi. 2003; 3(3): 230 - 235.
IEEE	GÜVEN A,KÖKSAL N,BÜYÜKBEŞE M,cetinkaya A,Sökmen G,AKSU E,ÇAĞLAYAN Ç "Effects of using a different kind of smokeless tobacco on cardiac parameters: "Maraş powder"." Anadolu Kardiyoloji Dergisi, 3, ss.230 - 235, 2003.
ISNAD	GÜVEN, Aytekin vd. "Effects of using a different kind of smokeless tobacco on cardiac parameters: "Maraş powder"". Anadolu Kardiyoloji Dergisi 3/3 (2003), 230-235.